HHS adds new anthrax drug to national stockpile

first_img Oct 6, 2005 CIDRAP News article “HHS to buy two anthrax drugs for testing” The HHS had previously awarded Cangene and another company, Human Genome Sciences, Inc., of Rockville, Md., contracts to test two experimental anthrax drugs. “Our first line of defense against anthrax is antibiotics,” said HHS assistant secretary for public health emergency preparedness Craig Vanderwagen, MD. “While additional studies are underway to determine its efficacy and ultimate role in treatment, AIG may have the potential to provide physicians with a source of human antibodies against the anthrax toxin that could improve the management of patients with the life-threatening toxemia associated with severe anthrax.” B anthracis is classified as a category A bioweapon. Anthrax spores sent through the US mail in the fall of 2001 caused 22 cases of anthrax,11 cutaneous and 11 inhalational. Five patients with the latter form died. The source of the anthrax has never been identified. Jul 28 HHS press release on adding AIG to the national stockpilehttp://archive.hhs.gov/news/press/2006pres/20060728.html See also: Jul 31, 2006 (CIDRAP News) – The US government announced Jul 28 that it will add 10,000 courses of anthrax immune globulin (AIG) to the strategic national stockpile. Toxins produced by the anthrax bacteria are believed to be a major cause of mortality in infected patients. The HHS says AIG is a potentially promising addition to the options physicians have to prevent and treat anthrax infections. In a press release Jul 28, the Department of Health and Human Services (HHS) said it awarded a $143,833,719 contract to Cangene, based in Winnipeg, Man. Deliveries of AIG, used to prevent or treat inhalational anthrax cause by Bacillus anthracis, to the stockpile are expected to begin in 2007. Full payment to Cangene hinges on the product being approved by the US Food and Drug Administration (FDA); however, the contract permits delivery of the product before FDA approval in an emergency.last_img read more

Indonesian badminton national athletes protected by BP Jamsostek

first_imgMembers of the national badminton team have been registered as active participants of the BP Jamsostek social security program, previously known as the Workers Social Security Agency (BPJS Ketenagakerjaan). The program covers job-related illness and injuries, as well as death. The athletes are under the patronage of the Indonesian Badminton Association (PBSI), the association said in a statement on Thursday.The PBSI went on to say that their careers exposed shuttlers to injury, which may occur during training and competitions. The association hopes the social security program will give the shuttlers financial assurance to allow them to fully focus on their day-to-day duties. “The social security program is also a form of appreciation for the shuttlers,” said PBSI operational director Alex Tirta.Read also: Indonesia’s junior shuttlers showered with cash rewards over World Cup successMeanwhile, the head of BP Jamsostek’s Jakarta Ceger branch, Dani Santoso, said he appreciated the PBSI’s gesture.“The utmost appreciation goes out to the PBSI, which has supported the government’s program and paid attention to risks encountered by athletes,” he added.Shuttler Pitha Haningtyas Mentari said she was happy with the plan, which gave athletes a sense of assurance in regard to their health. (nkn)Topics :last_img read more